Skip to content
value.today
Fractyl Laboratories Inc. logo

Fractyl Laboratories Inc.

Total raised
$270 M
6 rounds on record
Latest round
$100 M
Jun 2021
First round on record
Mar 2013
Today
Went public
See the company page

Fractyl Laboratories Inc. is listed today as Fractyl Health, Inc.: market value, financials and filings are on its company page.

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Fractyl Laboratories Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2021$100 MNo. 6$50 to $250 million

Fractyl Laboratories Inc.: Raise no. 6, Jun 2021

Investors in this round

15 investors had bought by the notice of Jun 22, 2021: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 24 investors are named for Fractyl Laboratories Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$100 M of $100 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Harith Rajagopalan · Executive Officer, Director
  • Jay Caplan · Executive Officer
  • Juan Carlos Lopez-Talavera · Executive Officer
  • Lisa Davidson · Executive Officer
  • Margaret Borys · Executive Officer
  • Ajay Royan · Director
  • Allan Will · Director
  • Amy Schulman · Director
  • Brian Dovey · Director
  • Clive Meanwell · Director
  • Marc Elia · Director
  • Michael Huang · Director
  • William Bradley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Harith Rajagopalan, Chief executive officer. Source: SEC Form D, newest notice filed Jun 22, 2021. Read the notice at the SEC.

equitySEC
Mar 2020$45 MNo. 5$10 to $50 million

Fractyl Laboratories Inc.: Raise no. 5, Mar 2020

Investors in this round

15 investors had bought by the notice of Mar 19, 2020: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 24 investors are named for Fractyl Laboratories Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$45 M of $45 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$468,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Harith Rajagopalan · Executive Officer, Director
  • Jay Caplan · Executive Officer
  • Juan Carlos Lopez-Talavera · Executive Officer
  • Lisa Davidson · Executive Officer
  • Margaret Borys · Executive Officer
  • Ajay Royan · Director
  • Allan Will · Director
  • Amy Schulman · Director
  • Brian Dovey · Director
  • Christopher Gabrieli · Director
  • John Amatruda · Director
  • Stanley Lapidus · Director
  • William Bradley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Harith Rajagopalan, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 19, 2020. Read the notice at the SEC.

equitySEC
Jun 2017$44 MNo. 4$10 to $50 million

Fractyl Laboratories Inc.: Raise no. 4, Jun 2017

Investors in this round

19 investors had bought by the notice of Dec 15, 2017: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 24 investors are named for Fractyl Laboratories Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$44 M of $44 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$250,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks finders' fees as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Harith Rajagopalan · Executive Officer, Director
  • Jay Caplan · Executive Officer
  • Lisa Davidson · Executive Officer
  • Ajay Royan · Director
  • Allan Will · Director
  • Brian Dovey · Director
  • Christopher Gabrieli · Director
  • John Amatruda · Director
  • Stanley Lapidus · Director
  • William Bradley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Harith Rajagopalan, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Dec 15, 2017. Read the notice at the SEC.

equitySEC
Oct 2015$47 MNo. 3$10 to $50 million

Fractyl Laboratories Inc.: Raise no. 3, Oct 2015

Investors in this round

16 investors had bought by the notice of Feb 19, 2016: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 24 investors are named for Fractyl Laboratories Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$47 M of $47 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Harith Rajagopalan · Executive Officer, Director
  • Jay Caplan · Executive Officer, Director
  • Lisa Davidson · Executive Officer
  • Ajay Royan · Director
  • Allan Will · Director
  • Christopher Gabrieli · Director
  • Nimesh Shah · Director
  • Stanley Lapidus · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Harith Rajagopalan, CEO and Secretary. Source: SEC Form D and 1 amendment, newest notice filed Feb 19, 2016. Read the notice at the SEC.

equitySEC
Aug 2014$20 MNo. 2$10 to $50 million

Fractyl Laboratories Inc.: Raise no. 2, Aug 2014

Investors in this round

13 investors had bought by the notice of Sep 3, 2014: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 24 investors are named for Fractyl Laboratories Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$20 M of $49 M offered; $29 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Diane Marcou · Executive Officer
  • Harith Rajagopalan · Executive Officer, Director
  • Jay Caplan · Executive Officer, Director
  • Ajay Royan · Director
  • Allan Will · Director
  • Christopher Gabrieli · Director
  • Nimesh Shah · Director
  • Stanley Lapidus · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Harith Rajagopalan, CEO and Secretary. Source: SEC Form D, newest notice filed Sep 3, 2014. Read the notice at the SEC.

equitySEC
Mar 2013$14 MNo. 1$10 to $50 million

Fractyl Laboratories Inc.: Raise no. 1, Mar 2013

Investors in this round

11 investors had bought by the notice of Mar 21, 2013: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 24 investors are named for Fractyl Laboratories Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$14 M of $14 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Diane Marcou · Executive Officer
  • Harith Rajagopalan · Executive Officer, Director
  • Jay Caplan · Executive Officer, Director
  • Allan Will · Director
  • Brian H. Dovey · Director
  • Christopher H. Gabrieli · Director
  • Hemant Taneja · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Harith Rajagopalan, CEO and Secretary. Source: SEC Form D, newest notice filed Mar 21, 2013. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Fractyl Laboratories Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2021).

    SEC Form D · Jun 2021

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jun 2021

That is all the official record says: Fractyl Laboratories Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Fractyl Laboratories Inc. are on record.

Investors#

24 named in official filings. Open an investor to see everything it has backed.

Investors in Fractyl Laboratories Inc.
InvestorKindAmountRoundRoleSource
American Home Assurance CoOthernot statednot statedHeld Series E and F preferred stock, 10% owner (Form 3, 2024)SEC Form 3
American International Group IncCompanynot statednot statedHeld Series E and F preferred stock, 10% owner (Form 3, 2024)SEC Form 3
Bessemer Venture Partners VII Institutional L.P.Venture capitalnot statednot statedHeld Series A, B, C-1, C-2, D and E preferred stock, 10% owner (Form 3, 2024)SEC Form 3
Bessemer Venture Partners VII L.P.Venture capitalnot statednot statedHeld Series A, B, C-1, C-2, D and E preferred stock, 10% owner (Form 3, 2024)SEC Form 3
BVP VII Special Opportunity Fund LPFund or asset managernot statednot statedHeld Series A, B, C-1, C-2, D and E preferred stock, 10% owner (Form 3, 2024)SEC Form 3
Corebridge DECO II, LLCOthernot statednot statedHeld Series E and F preferred stock, 10% owner (Form 3, 2024)SEC Form 3
CVF LLCOthernot statednot statedHeld Series D, E and F preferred stock, 10% owner (Form 3, 2024)SEC Form 3
Deerfield Management Company, L.P.Fund or asset managernot statednot statedHeld Series C-2 and D preferred stock, 10% owner (Form 3, 2024)SEC Form 3
Deerfield Mgmt III, L.P.Fund or asset managernot statednot statedHeld Series C-2 and D preferred stock, 10% owner (Form 3, 2024)SEC Form 3
Deerfield Private Design Fund III, L.P.Fund or asset managernot statednot statedHeld Series C-2 and D preferred stock, 10% owner (Form 3, 2024)SEC Form 3
Deer VII & Co. L.P.Fund or asset managernot statednot statedHeld Series A, B, C-1, C-2, D and E preferred stock, 10% owner (Form 3, 2024)SEC Form 3
Deer VII & Co. Ltd.Companynot statednot statedHeld Series A, B, C-1, C-2, D and E preferred stock, 10% owner (Form 3, 2024)SEC Form 3
GC Entrepreneurs Fund V, LPFund or asset managernot statednot statedHeld Series A, B, C-1, C-2, D and E preferred stock, 10% owner (Form 3, 2024)SEC Form 3
General Catalyst GP V, LLCOthernot statednot statedHeld Series A, B, C-1, C-2, D and E preferred stock, 10% owner (Form 3, 2024)SEC Form 3
General Catalyst Group V LPFund or asset managernot statednot statedHeld Series A, B, C-1, C-2, D and E preferred stock, 10% owner (Form 3, 2024)SEC Form 3
General Catalyst Partners V, L.P.Fund or asset managernot statednot statedHeld Series A, B, C-1, C-2, D and E preferred stock, 10% owner (Form 3, 2024)SEC Form 3
Harith RajagopalanPersonnot statednot statedHeld Series A preferred stock, director (Form 3, 2024)SEC Form 3
HCC Manager LLCOthernot statednot statedHeld Series D, E and F preferred stock (Form 3, 2024)SEC Form 3
M28 Capital Management LPFund or asset managernot statednot statedHeld Series F preferred stock, director (Form 3, 2024)SEC Form 3
Mithril GP LPFund or asset managernot statednot statedHeld Series C-1, C-2, D, E and F preferred stock, 10% owner (Form 3, 2024)SEC Form 3
Mithril II GP LPFund or asset managernot statednot statedHeld Series C-1, C-2, D, E and F preferred stock, 10% owner (Form 3, 2024)SEC Form 3
Mithril II LPFund or asset managernot statednot statedHeld Series C-1, C-2, D, E and F preferred stock, 10% owner (Form 3, 2024)SEC Form 3
Mithril II UGP LLCOthernot statednot statedHeld Series C-1, C-2, D, E and F preferred stock, 10% owner (Form 3, 2024)SEC Form 3
Mithril LPFund or asset managernot statednot statedHeld Series C-1, C-2, D, E and F preferred stock, 10% owner (Form 3, 2024)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 19 investors.

Largest shareholders today

Institutions holding Fractyl Health, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Fractyl Laboratories Inc.
NameRoleNamed in
Harith RajagopalanExecutive officerJun 2021
Jay CaplanExecutive officerJun 2021
Juan Carlos Lopez-TalaveraExecutive officerJun 2021
Lisa DavidsonExecutive officerJun 2021
Margaret BorysExecutive officerJun 2021
Diane MarcouExecutive officerSep 2014
Ajay RoyanDirectorJun 2021
Allan WillDirectorJun 2021
Amy SchulmanDirectorJun 2021
Brian DoveyDirectorJun 2021
Clive MeanwellDirectorJun 2021
Harith RajagopalanDirectorJun 2021
Marc EliaDirectorJun 2021
Michael HuangDirectorJun 2021
William BradleyDirectorJun 2021
Christopher GabrieliDirectorMar 2020
John AmatrudaDirectorMar 2020
Stanley LapidusDirectorMar 2020
Jay CaplanDirectorFeb 2016
Nimesh ShahDirectorFeb 2016
Brian H. DoveyDirectorMar 2013
Christopher H. GabrieliDirectorMar 2013
Hemant TanejaDirectorMar 2013

About

Company in Lexington, United States.

Went public since 2024. Its SEC number is that of a company listed on a stock exchange.